TY - JOUR
T1 - Choroidal neovascularization in a teenager with Kearns Sayre syndrome
AU - Ehrenberg, Miriam
AU - Dotan, Assaf
AU - Gal-Or, Orly
AU - Dotan, Gad
AU - Ehrlich, Rita
AU - Sternfeld, Amir
N1 - Publisher Copyright:
© 2025 Taylor & Francis Group, LLC.
PY - 2025
Y1 - 2025
N2 - Background: Kearns Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder. KSS primarily targets energy supply in cells through impaired oxidative metabolism and reduced ATP (Adenosine triphosphate) production. KSS is clinically characterized by a classic triad of chronic progressive external ophthalmoplegia, retinitis pigmentosa and cardiac conduction defect. Additional features may include neurological abnormalities, endocrinopathies, renal disease, growth failure, myopathy and more. Materials and Methods: We present a case of a young male with KSS, retinal dystrophy and multiple systemic abnormalities. Results: Despite treatment with three intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, the CNV demonstrated limited response and progressive enlargement, leading to poor final visual outcome. Conclusion: To our knowledge, CNV has not been previously documented in Kearns -Sayre syndrome. This report underscores the need for ongoing surveillance in patients with rare retinal dystrophies, given the potential for unforeseen complications.
AB - Background: Kearns Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder. KSS primarily targets energy supply in cells through impaired oxidative metabolism and reduced ATP (Adenosine triphosphate) production. KSS is clinically characterized by a classic triad of chronic progressive external ophthalmoplegia, retinitis pigmentosa and cardiac conduction defect. Additional features may include neurological abnormalities, endocrinopathies, renal disease, growth failure, myopathy and more. Materials and Methods: We present a case of a young male with KSS, retinal dystrophy and multiple systemic abnormalities. Results: Despite treatment with three intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, the CNV demonstrated limited response and progressive enlargement, leading to poor final visual outcome. Conclusion: To our knowledge, CNV has not been previously documented in Kearns -Sayre syndrome. This report underscores the need for ongoing surveillance in patients with rare retinal dystrophies, given the potential for unforeseen complications.
KW - choroidal neovascularization (CNV)
KW - Kearns Sayre syndrome
KW - retinal dystrophy
UR - https://www.scopus.com/pages/publications/105019065750
U2 - 10.1080/13816810.2025.2572711
DO - 10.1080/13816810.2025.2572711
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 41087305
AN - SCOPUS:105019065750
SN - 1381-6810
JO - Ophthalmic Genetics
JF - Ophthalmic Genetics
ER -